Surveillance for antimicrobial resistance in Croatia

被引:25
作者
Tambic Andrasevic, A [1 ]
Tambic, T
Kalenic, S
Jankovic, V
机构
[1] Univ Zagreb, Univ Hosp Infect Dis Dr Fran Mihaljevic, Dept Clin Microbiol, Mirogojska 8, Zagreb 10000, Croatia
[2] Croatian Acad Med Sci, Zagreb, Croatia
[3] Univ Zagreb, Clin Hosp Ctr, Zagreb, Croatia
[4] Croatian Natl Inst Publ Hlth, Zagreb, Croatia
关键词
D O I
10.3201/eid0801.010143
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe the activities of the Croatian Committee for Antibiotic Resistance Surveillance and report surveillance results for 1999. Twenty-two Croatian microbiology laboratories participated in the study. Resistance rates for the organisms isolated in different centers varied widely, but certain trends were apparent. Penicillin resistance in pneumococci (38%), methicillin resistance in Staphylococcus aureus (22%), the production of extended spectrum beta-lactamases by Klebsiella pneumoniae (21%), and imipenem resistance in Pseudomonas aeruginosa (11%) represent major resistance problems, especially in large hospitals. A comprehensive system of antimicrobial resistance surveillance, combined with training and external quality control programs, has identified high rates of resistance in key pathogens in some regions of Croatia. The program has heightened awareness of the problems of antimicrobial resistance and contributed to ongoing improvements in laboratory practice.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 17 条
[1]  
Andrasevic A T, 1999, Clin Microbiol Infect, V5, P634, DOI 10.1111/j.1469-0691.1999.tb00421.x
[2]  
[Anonymous], 1997, WHOTB97229
[3]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[4]  
BRUNBUISSON C, 1987, LANCET, V2, P302
[5]   Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-98 [J].
Doern, GV ;
Brueggemann, AB ;
Huynh, H ;
Wingert, E ;
Rhomberg, P .
EMERGING INFECTIOUS DISEASES, 1999, 5 (06) :757-765
[6]   Antibiotic resistance [J].
Finch, RG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :125-128
[7]   EXTENDED-SPECTRUM BETA-LACTAMASE IN SALMONELLA SPP [J].
ISSACK, MI ;
SHANNON, KP ;
QURESHI, SA ;
FRENCH, GL .
JOURNAL OF HOSPITAL INFECTION, 1995, 30 (04) :319-321
[8]  
Kalenic S, 1997, Lijec Vjesn, V119, P298
[9]  
*NAT COMM CLIN LAB, 1997, M100S7 NAT COMM CLIN
[10]  
National Committee for Clinical Laboratory Standards, 1997, M2A6 NAT COMM CLIN L